The two companies aim to reduce administrative burden and speed up drug delivery
Category: News
Winners will receive metabolomics kits, expert consultation and measurement services
Cell and gene therapies are often delayed by technical and regulatory issues
New consultancy aims to deliver personalised senior expertise in healthcare communications
Results show disease control and tumour shrinkage with GNS561 and MEK inhibitor combination
Trial shows GRI-0621 improved lung function with signs of fibrosis resolution
MajesTEC-3 study supports teclistamab plus daratumumab SC as potential standard of care
Proof-of-concept phase begins with first patient enrolled
Gene therapy shows sustained benefit for adults with haemophilia B
